We have developed a thiol-modified nanoporous silica material (SH-SAMMS) as an oral therapy for the prevention and treatment of heavy metal poisoning. SH-SAMMS has been reported to be highly efficient at capturing heavy metals in biological fluids and water. Herein, SH-SAMMS was examined for efficacy and safety in both in vitro and in vivo animal models for the oral detoxification of heavy metals. In simulated gastrointestinal fluids, SH-SAMMS had a very high affinity (Kd) for methyl mercury (MeHg(I)), inorganic mercury (Hg(II)), lead (Pb(II)), and cadmium (Cd(II)) and was superior to other SAMMS with carboxylic acid or phosphonic acid ligands or commercially available metal chelating sorbents. SH-SAMMS also effectively removed Hg from biologically digested fish tissue with no effect on most nutritional minerals found in fish. SH-SAMMS could hold Hg(II) and MeHg(I) tightly inside the nanosize pores, thus preventing bacteria from converting them to more absorbable forms. Rats fed a diet containing MeHg(I), Cd(II), and Pb(II) and SH-SAMMS for 2 weeks had blood Hg levels significantly lower than rats fed the metal-rich diet only. Upon cessation of the metal-rich diet, continued administration of SH-SAMMS for 2 weeks facilitated faster and more extensive clearance of Hg than in animals not continued on oral SH-SAMMS. Rats receiving SH-SAMMS also suffered less weight loss as a result of the metal exposure. Retention of Hg and Cd in major organs was lowest in rats fed with SH-SAMMS throughout the entire four weeks. The reduction of blood Pb by SH-SAMMS was significant. SH-SAMMS was safe to intestinal epithelium model (Caco-2) and common intestinal bacteria (Escherichia coli). Altogether, it has great potential as a new oral drug for the treatment of heavy metal poisoning. This new application is enabled by the installation of tailored interfacial chemistry upon nontoxic nanoporous materials.
We have developed a thiol-modified nanoporous silica material (SH-SAMMS) as an oral therapy for the prevention and treatment of heavy metalpoisoning. SH-SAMMS has been reported to be highly efficient at capturing heavy metals in biological fluids and water. Herein, SH-SAMMS was examined for efficacy and safety in both in vitro and in vivo animal models for the oral detoxification of heavy metals. In simulated gastrointestinal fluids, SH-SAMMS had a very high affinity (Kd) for methyl mercury (MeHg(I)), inorganic mercury (Hg(II)), lead (Pb(II)), and cadmium (Cd(II)) and was superior to other SAMMS with carboxylic acid or phosphonic acid ligands or commercially available metal chelating sorbents. SH-SAMMS also effectively removed Hg from biologically digested fish tissue with no effect on most nutritional minerals found in fish. SH-SAMMS could hold Hg(II) and MeHg(I) tightly inside the nanosize pores, thus preventing bacteria from converting them to more absorbable forms. Rats fed a diet containing MeHg(I), Cd(II), and Pb(II) and SH-SAMMS for 2 weeks had blood Hg levels significantly lower than rats fed the metal-rich diet only. Upon cessation of the metal-rich diet, continued administration of SH-SAMMS for 2 weeks facilitated faster and more extensive clearance of Hg than in animals not continued on oral SH-SAMMS. Rats receiving SH-SAMMS also suffered less weight lossas a result of the metal exposure. Retention of Hg and Cd in major organs was lowest in rats fed with SH-SAMMS throughout the entire four weeks. The reduction of blood Pb by SH-SAMMS was significant. SH-SAMMS was safe to intestinal epithelium model (Caco-2) and common intestinal bacteria (Escherichia coli). Altogether, it has great potential as a new oral drug for the treatment of heavy metalpoisoning. This new application is enabled by the installation of tailored interfacial chemistry upon nontoxic nanoporous materials.
Heavy metal exposure
is a growing health problem worldwide. For example, in 2010, the United
Nations Environment Programme (UNEP) reported that nearly two kilotons
of mercury were released into air and one kiloton into water, largely
from artisanal gold mining and the burning of fossil fuels. In the
environment, bacteria convert Hg to methyl mercury (MeHg(I)), which
is ultimately consumed by humans via fish and shellfish. A second
major source of Hg exposure is silver–mercury amalgam used
in dental restorations. Amalgam has been phased out in several European
countries but is still widely used in the USA and many other countries.
A recent risk analysis of data from several studies including 3800
subjects in US National Health and Nutrition Examination (NHANES)[1] revealed that amalgam dental restorations (50%
metallic mercury) were a major source of Hg exposure in the US. The
several studies considered in the risk analysis showed that Hg content
in urine, feces, exhaled breath, saliva, blood, and kidney, liver,
brain, and pituitary gland increases with increasing amalgam number.
In the most conservative risk scenario,[1] 67.2 million Americans would exceed the Hg reference exposure level
established by the US Environmental Protection Agency (0.5 to 1 μg/day/filled
tooth). In a separate analysis of NHANES data, Laks[2] reported that blood inorganic Hg levels in 6174 U.S. women
increased sharply with age over the last two decades. In other studies,
Hg has been observed to increase in amniotic fluid, placenta, fetal
tissues, and breast milk with increasing maternal amalgams[3] placing the developing infants and neonates at
an increased risk of Hg exposure. In addition to its dental, mining,
and other industrial uses, Hg figures in traditional religious rituals
and remedies throughout the world.[4]Elemental liquid mercury (Hg(0)) easily vaporizes and is inhaled
and oxidized by heme peroxidases in the blood to reactive inorganic
Hg(II), which spontaneously combines with biochemical thiols such
ascysteine and glutathioneas well ascysteinyl residues at key sites
in enzymes and other proteins.[5,6] Once in circulation,
Hg(II)-thiol conjugates partition into all tissues and those which
go to the liver are susceptible to enterohepatic recirculation. Hg-resistant
bacteria in the gastrointestinal tract may also convert Hg(II)-thiols
into volatile, membrane permeable Hg vapor, capable of transiting
back into circulation.[7−9] In addition, oral and intestinal bacteria can use
amalgam-derived Hg to form methyl mercury, which is readily absorbed
by the oral epithelium.[10] These bacterial
transformations and other reports on the Hg enterohepatic cycle make
clear that the effective elimination of Hg in any form from the body
requires keeping it away from bacteria while getting it through the
gastrointestinal tract, which is the route for >90% of Hg ingested
or inhaled.[6]Apart from treating
acute Hg exposure with chelating agents developed decades ago, such
asDimercaprol (British anti-Lewisite or BAL), 2,3-dimercapto-1-propanesulfonic
acid (DMPS), and 2,3-dimercaptosuccinic acid (DMSA or succimer), medical
practice has no formally adopted practicum for subacute, chronic (e.g.,
occupational or iatrogenic) metal exposure. Thus, persons who consider
themselves to suffer chronic metal exposure often use commercial naturopathic
or homeopathic remedies advertised for removal of harmful metals.
These include N-acetylcysteine (NAC), glutathione (GSH), selenocysteine,
zinc, charcoal, zeolite, EDTA, and alginate. However, none of these
materials have FDA approval and there is limited or no peer-reviewed
scientific evidence to validate marketing claims that they are effective
and safe for mercury detoxification.Our objective is to develop
a new oral treatment for heavy metalpoisoning based on thiol-modified
nanoporous silica (SH-SAMMS) with a specific focus upon Hg. Self-assembled
monolayers on mesoporous supports (SAMMS) are hybrid materials generated
by functionalizing mesoporous silica (SiO2) by covalently
binding organic moieties to the silica surface and then cross-linking
the organics to create a “dense molecular rug”. SAMMS
are highly efficient sorbents with superior properties over conventional
sorbents. Their multiligand chelation ability enhances their binding
affinity and stability. The high surface area of the porous silica
substrate (∼1000 m2/g) and the monolayer self-assembly
technique achieves functional group density up to 10-fold higher than
simpler methods[11−13] and consequent high metal loading capacity. SAMMS’
rigid, open channel structure is ideal for mass transport of metal
ions. We have successfully tailored the interfacial chemistry on the
SAMMS to be selective for toxic heavy metals,[12−14] transition
metals,[15,16] lanthanides and actinides,[17−22] oxometallic anions,[23,24] and cesium and thallium.[25,26] By exploiting nontoxic nanoporous materials with a well-designed
surface chemistry, we aim to achieve an oral therapy that is safe
and effective for daily, long-term use in chronic heavy metal exposure,
as well as enhancing the effectiveness of conventional chelating agents
in acute heavy metalpoisoning. This could have a high impact to public
health worldwide. The principle focus of this study is Hg, but it
will be shown that SH-SAMMS also has therapeutic potential for lead,
cadmium, and arsenic exposure.Our previous report in this
ACS AMI journal[12] suggests that SH-SAMMS
possesses many desired characteristics for oral mercury detoxification.
The linear rigid channels of the mesoporous silica make the thiol
sites readily available to metal ions. More than 99% of Hg in simulated
gastric fluid (SGF, pH 1.1) was removed in 3 min, just as observed
with other metals, Cd(II) in simulated intestinal fluid (SIF, pH 6.8)[12] and Pb(II) in natural waters.[14] In contrast, swellable polymer ion exchange resins, such
asGT-73, took much longer (∼120 min) to reach steady-state
sorption.[14] Fast binding kinetics is advantageous
for rapid capture of toxic metals in the GI tract to minimize reabsorption
back to the body. The extent of Hg capture on SH-SAMMS was stable
over a 24-h exposure period tested, indicating no significant leaching
of Hg from the sorbent nor degradation of the SH-SAMMS in SGF. The
affinity of SH-SAMMS for Cd(II), Pb(II), and Hg(II) in gastrointestinal
fluids with a pH range of 1–8, chosen to cover physiological
pH’s along the gastrointestinal tract, has been reported.[12] SH-SAMMS’ affinity for Hg(II) was very
high (1 × 106 fold higher by weight of Hg on SH-SAMMS
than in the supernatant solution) across the whole pH range, while
those for Cd(II) and Pb(II) was high at pH > 5.5. The SH-SAMMS’
affinity for the metal ions was not significantly affected by increased
ionic strength from 0.001 to 0.1 M. When exposing SH-SAMMS bound with
Cd(II), Pb(II), and Hg(II) to Caco-2 cells (possessing many properties
of the intestinal epithelium), there was no leachate of the four
metal ions from SH-SAMMS across the Caco-2 monolayer and no decrease
in trans-epithelial electrical resistance (TEER) across the exposed
cell monolayers, thus SH-SAMMS did not damage the cell monolayer.
There was no cellular uptake of SH-SAMMS having particle size greater
than 5 μm.[12]Herein, we extend
the work to include other essential in vitro and in vivo studies to
show the great potential of SH-SAMMS for detoxification of heavy metals
in humans. The sorbent material can be simply administered orally
and the material properties are engineered for the therapy needs.
This novel application of the SAMMS materials is enabled by the installation
of tailored interfacial chemistry upon nontoxic nanoporous materials.
Experimental Section
Sorbent Materials
Synthesis and characterization of the SAMMS materials have been described
elsewhere, including SH-SAMMS,[13,27] AcPhos-SAMMS,[28] Gly-Ur-SAMMS,[22] and
IDAA-SAMMS.[16] Their chemical structures
are shown in Figure 1. The SH-SAMMS was synthesized
from MCM-41 with a pore size of 5.0 nm and a Brunauer–Emmett–Teller
(BET) surface area of 870 m2/g. After thiol functionalization,
the material had a pore size of 3.8 nm, a BET surface area of 438
m2/g, and a silane population of 3.9 thiol silanes/nm2 (determined using thermogravimetric analyzer, NETZCH STA
409 C/CD TGA). This high level of coverage forces the propyl chains
into an upright posture, and forces the thiols up to the monolayer/solution
interface. Additional characterization (e.g., 13C and 29Si NMR and TEM) of SH-SAMMS has been previously reported.[13]
Figure 1
Surface chemistries of various SAMMS materials explored
for toxic metal capture.
Surface chemistries of various SAMMS materials explored
for toxic metal capture.
Test Matrices
Batch metal sorption experiments were performed
with artificial gastric and intestinal fluids. The simulated gastric
fluid (SGF)[29] and simulated intestinal
fluid (SIF)[30] were prepared daily following
the recommendations of the U.S. Pharmacopeia for drug dissolution
studies in stomach and intestine, respectively. The SGF (pH 1.11)
contained 0.03 M NaCl, 0.085 M HCl, and 0.32% (w/v) pepsin. The SIF
contained 0.05 M KH2PO4; its pH was adjusted
to 6.8 with 0.2 M NaOH. Additional simulated intestinal fluids were
also utilized; including 0.2 M NaHCO3 (pH 8.30),[31,32] Krebs buffer (pH 6.80) consisting of 118.0 mM NaCl, 4.7 mM KCl,
1.2 mM MgSO4, 1.2 mM KH2PO4, 11.0
mM d-glucose, 2.5 mM CaCl2·H2O,
and 25.0 mM NaHCO3[33,34] and 0.05 M KH2PO4 (pH 6.80) with and without 10 mg/mL pancreatin.[29,30]
Kd Measurements
The affinity
of a sorbent for a target species is represented by a distribution
coefficient (Kd) (mL/g). Kd is a mass-weighted partition coefficient between the
solid phase and the liquid phase as followswhere Co and Cf are initial and final
metal ion concentrations in solution determined by ICP-MS, V is solution volume in mL, and M is mass
(g) of sorbent. For Kd measurements, the
test solutions were spiked with multiple heavy metal ions (Cd(II),
Hg(II), Pb(II)) and trivalent arsenic (As(III)) from chloride salts
to obtain 50 μg/L each. A similar experiment was performed with
only MeHg(I) from MeHgCl. A sorbent material was then added to the
solution to obtain a solid per liquid ratio (S/L) of 0.2 g/L. The
control was performed in the same fashion but without solid sorbent.
The sample was then shaken for 2 h at 200 rpm on an orbital shaker.
After 2 h, the solid was removed by centrifugation at 16 100g for 5 min and the supernatant was kept in 1 wt % HNO3 and 1 ppm Au to stabilize Hg species prior to the metal analysis.
The metal concentrations in the control (no sorbent) and the test
solutions (after being contacted with a sorbent material) were analyzed
using an inductively coupled plasma-mass spectrometer (ICP-MS, Agilent
7500x, Agilent Technologies, CA). Every experiment was conducted with
appropriate controls (same metal solution with no sorbent), that underwent
the same experimental conditions (including centrifuge) with the test
group containing SH-SAMMS. This was to ensure that the difference
in metal content between the control and the SH-SAMMS treated groups
was due to the SH-SAMMS and not due to the metal oxide precipitation
at high pH. It is also noted that based on the Ksp of metal hydroxides (e.g., Ksp ∼10–20 for Cu(OH)2 and Pb(OH)2),[35,36] the precipitation is negligible when the metal content (50 ppb)
and the hydroxide content (pH 6.8) are low as in our studies. All
batch experiments were performed in triplicate and the averaged values
and standard deviation were reported.
Hg Sorption Isotherms
The adsorption isotherm of Hg (as Hg(II) and MeHg(I)) is a measure
of sorption capacity (in mg Hg/g SH-SAMMS) as a function of the equilibrium
concentration of Hg in solution (in mg Hg/L). The adsorption isotherm
was measured in deionized water spiked with mercury (final pH 4.0)
at room temperature. The experiment was similar to Kd measurement but Hg concentrations were increased until
the thiol binding sites were saturated (e.g., 0–2000 mg/L Hg
conc; S/L of 0.2 g/L).
Competition by GSH
SH-SAMMS was
incubated with an excess (7.5 mM) of either Hg(II) or MeHg(I) on an
orbital shaker at 200 rpm and room temperature for 2 h to achieve
loading of 350 mg Hg as Hg(II) or 250 mg Hg (as MeHg(I)) per gram
of SH-SAMMS. The amount of Hg loaded on SH-SAMMS was determined by
ICP-MS in the same fashion as the Kd measurement experiment.
The Hg-loaded SH-SAMMS (Hg–S–SAMMS) were then washed
three times with deionized water (500 mL/g of SH-SAMMS for each wash)
to remove the unbound Hg species and finally resuspended at 5 mg/mL.
The Hg–S–SAMMS was incubated by stirring at 200 rpm
with 10 mM glutathione (GSH) for 4 h at 37 °C. The amount of
Hg leached from the Hg–S–SAMMS was measured in the supernatant
fluid by ICP-MS.
In Vitro Capture of Hg from Fish
Various predator fish (kingfish, shark, Chilean seabass, red tuna,
and white tuna) were purchased from a supermarket in Portland, OR,
and quantified for total Hg content. Kingfish muscle containing 1.29
± 0.03 mg total Hg/kg (wet weight), higher than FDA action level
of 1.0 mg/kg, was selected for the study. Prior to mixing with SH-SAMMS,
the fish was digested using a process shown in Figure 2. Briefly, gastric digestion was simulated by incubating 8
g of fish muscle on an orbital shaker at 150 rpm in 80 mL of 0.075
M HCl and 0.3% pepsin (pH 1.6) for 3 h at 37 °C. This was followed
by 1 h of intestinal digestion simulation by adjusting the suspension’s
pH to 5.0 with 1.0 M NaHCO3 and adding pancreatin (a hog
pancreas extract containing amylase, lipase, and protease activities)
and bile extract to 0.0025 and 0.015 wt %, respectively. SH-SAMMS
were added to the fish tissue suspension at 0.5–2.5 g/L after
2 h of gastric digestion and remained in the suspension during the
intestinal digestion. After the gastric and intestinal digestions,
the suspensions were centrifuged at 16 100g for 15 min to pellet the SH-SAMMS and the mineral content of the
supernatant was determined by ICP-MS. A control fish tissue was digested
without SH-SAMMS. The wt % Hg removed and wt % change of other minerals
by SH-SAMMS were compared with the control.
Figure 2
Schematic of in vitro
fish digestion and SH-SAMMS treatment processes.
Schematic of in vitro
fish digestion and SH-SAMMS treatment processes.
Bacterial Conversion of Hg(II) Bound SH-SAMMS
The Escherichia coli MG1655 strains with or without the NR1
plasmid conferring mercury resistance via mercuric reductase expression[37,38] were cultured in Luria–Bertani Broth (10 g/L tryptone, 5
g/L yeast extract, 5 g/L NaCl, and 1 mM NaOH) at 37 °C (with
shaking at 200 rpm). Overnight cultures were diluted 100-fold into
fresh broth and incubated at 200 rpm for 3.5 h to reach their exponential
growth stage (absorbance at 600 nm, OD600, of 0.24), at
which time HgCl2 (0, 10, or 50 μM), SH-SAMMS (100
μg/mL), or Hg–S–SAMMS (100 μg/mL SH-SAMMS
with 1.2 mmol Hg(II)/g loaded) were added to replicate 10 mL aliquots
of the Hg-sensitive and Hg-resistant bacterial cultures. Growth of
the cultures was measured using OD600 at 0, 0.5, 1, 2,
4, 6, 10, 20, and 25 h after addition of HgCl2, SH-SAMMS
or Hg–S–SAMMS.
Cell Culture and Cytotoxicity Studies
Immortal human colon epithelial cells, Caco-2, were grown in Dulbecco’s
Modified Eagle’s Medium (DMEM, Corning/Cellgro, VA) supplemented
with 10% fetal bovine serum (GIBCO, Life Technologies, NY) and 1X
penicillin/streptomycin (Corning/Cellgro, VA). Cells were maintained
at 37 °C in 5% CO2 air atmosphere and were passaged
weekly by trypsinization (TrypLE, Life Technologies, NY). For cytotoxicity
assays, cells were subcultured and seeded at 3000 cells/well in 96-well
flat plates and grown to optimal confluency in 5 days. Cells were
then directly exposed to SH-SAMMS, DMSA, DMPS (0 – 10,000 μg/mL),
HgCl2 (0–0.32 mM), MeHgCl (0 – 0.04 mM) or
Hg–S–SAMMS for 24 h. The Hg–S–SAMMS used
had 0.16 mmol Hg(II) or MeHg(I) per gram of SH-SAMMS and were added
to the Caco-2 culture media to obtain Hg concentrations in the well
volume equivalent to those of soluble Hg counterparts above (e.g.,
Hg(II)-S-SAMMS was added at a dose of 2 mg/mL in cell culture well
to achieve the equivalent dose of 0.32 mM Hg(II)). After 24 h, cell
viability was quantified with the CellTiter-Glo Luminescent Cell Viability
Assay and normalized to an untreated control (e.g., no mercury compounds
or soluble chelators added).
Chemicals and Diet
Methylmercurychloride (CH3HgCl), cadmium chloride (CdCl2)
and lead acetate (Pb(CH3COO)2) were purchased
from Sigma Aldrich, USA. The rodent diet was Purina 5001 Rodent Chow
(St. Louis, MO). The metal-rich diet was prepared by mixing powdered
Purina 5001 with the aforementioned metal salts to achieve 0.01% by
weight of each metal per weight of the food (inherently having insignificant
amount of mercury (in ng/kg),[39] compared
to what was added). The SH-SAMMS-containing diet was prepared in the
same manner but with 1.0% by weight of SH-SAMMS per weight of the
food. All mixing was performed daily on dry material to avoid prebinding
of metals to SH-SAMMS prior to administering to the rats. The diet
was fed to ratsas dried powder and consumption (in gram) was recorded
daily.
Evaluation of Metals in Tissues and Blood Samples of Rats
Male Wistar rats weighing an average of 250 ± 10 g were purchased
from Charles River Laboratory (Wilmington, MA). They were placed individually
in metabolic cages (Tecniplast, Italy) during the entire period of
the study. All animals were maintained on a 12 h light cycle (6 a.m.
to 6 p.m.) and given water ad libitum. All animal experiments were
approved by OHSU’s IACUC and were carried out under the auspices
of the OHSU Department of Comparative Medicine.Three groups
of 8 week old rats (6/group) were fed rodent diets containing either:
(1) metal-rich diet (prepared as above); (2) a diet with 1.0 wt %
SH-SAMMS; or (3) a diet mixed with metalsas stated above and 1.0
wt % SH-SAMMS. The rats were fed for 2 weeks and then the metal-rich
diet was removed and the rats were regrouped (3/group) with half receiving
normal diet and the other half receiving 1.0 wt % SH-SAMMS diet for
an additional 2 weeks. Blood samples were collected from each animal
twice weekly for monitoring heavy metal concentration in the blood.
Rat body weight was measured daily except weekends. Then the rats
were sacrificed, and blood, liver, kidneys, brain, bone, and muscles
were collected. Blood and tissue samples were digested in concentrated
nitric acid until fully digested. Then the samples were diluted 50-fold
in deionized water prior to metal analysis by ICP-MS.
Results
and Discussion
Performance of Various Sorbent Materials
in Standard Simulated Gastrointestinal Fluids
Kd values are the solid phase analog to solution phase
equilibrium constants and are widely used to quantify a material’s
performance for trace collection. For low concentration levels typically
encountered with heavy metal exposure, Kd values are preferable to parameters such as total number of binding
sites or Langmuir isotherms, which assume higher concentrations and
sorbent saturation. For complex biological matrices Kd values of 500 mL/g are acceptable, those >5000 mL/g
are very good, and >50 000 mL/g are outstanding considering
the high ionic strength and organic content typically found in these
solutions.[22]In simulated gastric
fluid (SGF, pH 1.11), most cation chelators did not capture Cd(II),
Hg(II), Pb(II), and As(III) (Table 1), whereas SH-SAMMS strongly captured As and both Hg(II) and MeHg(I)
species as expected for a soft thiol ligand and soft metal ions according
to Pearson’s hard–soft–acid–base (HSAB)
principle that soft metal ions (Lewis acid) prefer to bind with soft
ligands (Lewis base) and hard metal ions prefer to bind with hard
ligands.[40] The thiol group starts off protonated,
and then loses the proton upon binding Hg. SH-SAMMS did not capture
Cd(II) and Pb(II) in SGF (pH 1.11), likely due to proton competition
with these borderline metal ions. IDAA-SAMMS (a variant of EDTA) and
activated carbon (Darco KB-B) marginally captured Hg compared to SH-SAMMS.
In simulated intestinal fluid (SIF, pH 6.8), SH-SAMMS was best for
all four metal ions (Table 1). Higher Kd values of Hg(II)
and MeHg(I) at pH 1.1 than at pH 6.8 may be attributed to increased
wettability of adduct in acidic conditions since SH-SAMMS itself is
mildly hydrophobic as a result of the propyl thiol coating.
Table 1
Affinities (Kd) of Four
SAMMS and Commercial Sorbent Materials (Chelex-100 resin, GT-73 resin,
and Darco KB-B Activated Carbon) for As(III), Cd(II), Hg(II), MeHg(I),
and Pb(II)
Kda (mL/g)
sorbent
As(III)
Cd(II)
Hg(II)
Pb(II)
in simulated gastric
fluid (pH 1.11)
SH-SAMMS
1700
170
1 500 000
for Hg(II)
0
170 000 for MeHg(I)
IDAA-SAMMS
0
44
690 000
0
AcPhos-SAMMS
340
120
1600
10
Gly-Ur-SAMMS
57
0
460
0
Chelex-100
0
0
4500
0
GT-73
0
0
1300
810
Darco KB-B AC
0
0
24000
0
in simulated intestinal
fluid (pH 6.80)
SH-SAMMS
27 000
770 000
270 000 for Hg(II)
20000
88 000 for MeHg(I)
IDAA-SAMMS
0
200 000
11 000
18000
AcPhos-SAMMS
0
47 000
5700
13000
Gly-Ur-SAMMS
0
840
500
4500
Chelex-100
0
38 000
47 000
12000
GT-73
0
1400
3200
3700
Darco KB-B AC
0
1100
80 000
15000
Measured at metal ion conc. of 50 μg/L (each), solid per liquid
ratio of 0.2 g/L.
Measured at metal ion conc. of 50 μg/L (each), solid per liquid
ratio of 0.2 g/L.The Kd values of the four metal ions for SH-SAMMS
in four different simulated intestinal fluids showed that typical
biotic anion electrolytes (chloride, phosphate, bicarbonate >0.05
M) did not impede sequestration of toxic metals by SH-SAMMS (Table 2). Table 2 also shows that SH-SAMMS has extremely high selectivity for heavy
metals over both alkaline and alkaline earth metal ions, considered
hard metal ions according to Pearson’s HSAB principle. This
is evidenced by the extremely high Kd for
the heavy metal ions in Krebs buffer (pH 6.80), which contained large
excess (by mole over that of Hg) of Na(I) (6 × 105 fold), K(I) (2.4 × 104 fold), Mg(II) (4.8 ×
103 fold), and Ca(II) (1 × 104 fold). SH-SAMMS
performed much better than the commercial thiol resin sorbent, GT-73,
likely due to the highly ordered and tightly packed thiol monolayers,
which better allow for bis-coordination of metal ions. Amorphous GT-73
may rarely present two thiols in close proximity to establish the
stronger multiligand S–Hg–S and S–Hg–O–Hg–S
complexation that typically occurs in SH-SAMMS.[13,41] We have previously reported SH-SAMMS to have much higher affinity
(1 × 102 fold higher in Kd) and capacity
(20-fold higher in capacity) for Hg(II) than GT-73, all measured in
filtered groundwater.[14] The IDAA-SAMMS
was much better than EDTA-based Chelex-100, likely also owing to better
ligand proximity affording higher order chelation. In both simulated
gastrointestinal fluids, SH-SAMMS captured metal ions much better
than the high surface area activated carbon (Darco KB-B), whose ligands
(carboxylates, phenols, etc.) are also randomly ordered. Thus, SH-SAMMS
was proven to be highly effective in vitro at sequestering Hg and
other toxic, thiophilic metals in standard simulated gastrointestinal
fluids.
Table 2
Affinity (Kd) of SH-SAMMS for As(III), Cd(II), Hg(II), and Pb(II) in Various
Simulated Intestinal Fluids
Kda (mL/g) in various simulated intestinal fluids
matrix
As(III)
Cd(II)
Hg(II)
Pb(II)
0.2 M NaHCO3 (pH 8.30)
26 000
3 600 000
1 300 000
1 300 000
Krebs buffer
(pH 6.80)
26 000
1 500 000
150 000
140 000
0.05 M H2KPO4 (pH 6.80)
27 000
770 000
270 000
20 000
0.05 M H2KPO4 (pH 6.80), with 10 mg/mL pancreatin
24 000
1 300 000
290 000
78 000
Measured at metal ion conc. of 50 μg/L (each), solid per liquid
ratio of 0.2 g/L.
Measured at metal ion conc. of 50 μg/L (each), solid per liquid
ratio of 0.2 g/L.
Hg Binding
Capacity of SH-SAMMS
The adsorption isotherms of Hg(II) and
MeHg(I) on SH-SAMMS, are well fitted by a Langmuir model (R2 >0.98) consistent with monolayer adsorption without precipitation
of the metals (Figure 3). We previously reported
this standard SH-SAMMS to contain 3.9 SH/nm2 or 2.8 mmol
SH/g.[12] Here we found (Figure 3) the maximum mercury binding capacities to be 385
mg/g for Hg(II) (1.9 mmol/g) and 250 mg for MeHg(II) (1.2 mmol/g).
The molar ratio of S and Hg(II) of 1.47 is in agreement with our previous
reports based on Extended X-ray Absorption Fine Structure (EXAFS)
approach indicating that Hg(II) binds to SH-SAMMS as a mixture of
S–Hg–O–Hg–-S (S/Hg = 1) and S–Hg–S
(S/Hg = 2).[41] The SH-SAMMS loading capacity
for Hg(II) in water was the same as in SGF (380 mg/g).[12] We also found the metal binding capacity of
SH-SAMMS was not affected by temperature from 24 to 37 °C as
expected for covalent bonding.[12] Lastly,
we have seen no evidence that binding Hg induces any agglomeration
of the silica particles.
Figure 3
Binding capacity of SH-SAMMS for inorganic Hg(II)
and MeHg(I) in deionized water (pH 4.0); data modeled with Langmuir
adsorption isotherm. All with SH-SAMMS at 0.2 g/L.
Binding capacity of SH-SAMMS for inorganic Hg(II)
and MeHg(I) in deionized water (pH 4.0); data modeled with Langmuir
adsorption isotherm. All with SH-SAMMS at 0.2 g/L.
Impact of other Thiol Compounds and Proteins
on SH-SAMMS Performance
Reduced glutathione (GSH) and cysteine
(CysH) are abundant in the GI tract and may compete with SH-SAMMS
for Hg. Since SH-SAMMS has a strong affinity for Hg even at low pH
(Table 1), it should capture Hg in the stomach
where levels of GSH and CysH are negligible,[42] while the thiol concentrations measured in human small intestines
were higher (e.g., from 3 to 8 mM).[43] After
SH-SAMMS loaded with Hg equivalent to 0.34 mM Hg(II) or 0.25 mM MeHg(I)
in solution were incubated with 10 mM GSH for 4 h at 37 °C, we
found that only 28 ± 0.1% of Hg(II) and 33 ± 1.7% of MeHg(I)
were released into the solution. Thus, SH-SAMMS retained ∼70%
of its Hg(II) or MeHg(I) load even when in equilibrium with small
monothiols capable of entering its interior channels. In contrast,
proteins (pepsin in SGF, Table 1 and pancreatin
in SIF, Table 2), which are too large to enter
the channels had no significant negative effect on the binding of
Hg(II) on SH-SAMMS, consistent with the idea that the small pore size
of SH-SAMMS excludes proteins that might foul metal binding sites
inside SAMMS channels.
SH-SAMMS Captured Hg from Fish Digestate
without Removing Most Essential Metals
SH-SAMMS effectively
captured Hg(II) and MeHg(I) in simulated gastric and intestinal fluids
as shown in Table 1, so we asked if they can
capture Hg from digested fish. Kingfish contained 1.29 ± 0.03
mg total Hg/kg-wet weight and over 90% of total Hg in predator fish
is methyl mercury.[44,45] The fish was digested by simulating
gastric and intestinal processes. After gastric digestion, soluble
Hg was 85% of total Hg and remained the same after simulated intestinal
digestion. We found 1.0 g/L of SH-SAMMS (added directly to the fish
digestion without removing fish particulates) captured 62 ± 1.4%
(n = 3) of soluble Hg (Table 3) after gastric digestion (pH 1.6) and 65 ± 0.7% (n = 3) after gastric + intestinal digestion (pH 5.0). Thus, Hg capture
could largely occur in the stomach and the Hg would remain bound at
higher pH with competing thiols in the large intestine (measured to
be 1.5 mM by Ellman’s assay from the same digested fish). In
contrast, 1.0 g/L of high surface area activated carbon (Darco KB-B)
only removed ∼16 and 24% of Hg after gastric and gastric+intestinal
digestion, respectively, consistent with lower Kd values
(Table 1) than for SH-SAMMS. Hg capture by
SH-SAMMS was dose-dependent with 25, 62, and 84% of fish Hg being
captured by 0.5, 1.0, and 2.5 g/L of SH-SAMMS, respectively. The fish
also contained a small amount of Pb, of which 49% was removed by SH-SAMMS
in the simulated digestate. Importantly, SH-SAMMS did not deplete
some Group I and II nutritional minerals from the fish tissue (i.e.,
Mg, K, Ca, Se, Rb, and Sr). In this in vitro test on the fish digestate,
SH-SAMMS did remove some trace nutritional transition metalsFe, Zn,
and Cu (Table 3), which could be soluble or
bound to biomolecules smaller than the pore size of SH-SAMMS (to be
accessible to thiol groups on the inner walls of SH-SAMMS). Removal
of essential minerals is common with systemically administered metal
chelators, DMSA, DMPS, or EDTA, but because SH-SAMMS acts only in
the GI tract such mineral-depleting side effects on the host organism
could be milder. We investigated this hypothesis in our animal studies
described below.
Table 3
SH-SAMMS (1.0 g/L) Capture of Metals
from in Vitro Fish Digestate
metal content (mg/kg fish-wet weight)
digestion stage
system
Mg
K
Ca
Fe
Cu
Zn
Se
Rb
Sr
Hg
Pb
gastric
untreat I
341 ± 3
4550 ± 31
57 ± 0
1.32 ± 0.32
0.31 ± 0.00
8.34 ± 0.09
3.74 ± 0.04
0.81 ± 0.01
0.32 ± 0.00
1.09 ± 0.02
0.005 ± 0.002
SH-SAMMS
340 ± 1
4540 ± 28
57 ± 0
1.12 ± 0.01
0.22 ± 0.01
8.34 ± 0.04
3.81 ± 0.04
0.81 ± 0.00
0.32 ± 0.00
0.41 ± 0.01
0.005 ± 0.000
% removal
0
0
0
16
30
0
0
0
0
62
0
gastric
+ intestinal
untreat
II
378 ± 14
5520 ± 300
70 ± 1
1.93 ± 0.05
0.27 ± 0.01
8.31 ± 1.49
3.34 ± 0.02
0.90 ± 0.00
0.37 ± 0.01
1.01 ± 0.09
0.004 ± 0.003
SH-SAMMS
363 ± 13
5090 ± 330
64 ± 3
1.42 ± 0.03
0.02 ± 0.00
6.93 ± 0.31
3.47 ± 0.11
0.88 ± 0.05
0.36 ± 0.02
0.35 ± 0.01
0.002 ± 0.000
% removal
4
8
9
26
94
17
0
2
2
65
49
Bacterial Access
to SH-SAMMS-Bound Hg
In the environment, bacterial methylation
of Hg(II) is an established component of Hg cycling; e.g., Hg(II)
is converted by bacteria in natural sediments to MeHg(I), which bioaccumulates
in fish and the higher food chain.[8,46] However, bacterial
biotransformation of Hg compounds is not limited to the external environment.
Summers et al. observed enrichment of Hg(II)-reducing bacteria in
the primate GI tract in response to Hg exposure from dental mercury
fillings.[47] The ability to reduce Hg(II)
makes the bacteria resistant to Hg(II) but the resulting monatomic
Hg(0) vapor may be absorbed back into circulation instead of being
excreted with feces.[5,6,48] More
recently, Summers’ group has also observed MeHg(I) formation
in the feces of monkeys fitted with amalgam restorations (manuscript
under review). Bacteria are typically spherical or rod-shape with
the dimension between 0.5 and 3 micrometer.[49] The small pores of SH-SAMMS, from 3.8 to 6.5 nm,[12] would prevent bacterial access to Hg(II) bound in SH-SAMMS’
interior channels and hence could limit bacterial reduction and methylation
of Hg(II) in the GI tract. We tested whether Hg bound to SAMMS is
accessible to bacteria by exposing cultures of Hg(II)-reducing (aka
“resistant”) E.coli and Hg(II)-nonreducing E.coli (aka “sensitive”)[50] to soluble Hg(II) (as HgCl2) or to Hg–S–SAMMS.
Two control cultures were those exposed to SH-SAMMS or untreated.
The culture growth was measured by absorbance at 600 nm for Hg-sensitive E. coli (Figure 4A) and for Hg-resistant E. coli (Figure 4B). Addition of
10 μM HgCl2 to early exponential phase cultures had
little effect on the growth of either E. coli strain
but 50 μM HgCl2 initially inhibited growth of both
strains. However, as expected the Hg-resistant strain recovered at
6 h after Hg addition and eventually reached a turbidity similar to
its growth in medium without HgCl2; the lag period reflects
the induction of the expression of the genes for mercury transformation.
In contrast, the Hg-sensitive strain never recovered from 50 μM
HgCl2 exposure since it cannot convert Hg(II) to less reactive,
volatile Hg(0). The addition of SH-SAMMS alone to the E. coli cultures did not affect growth of either strain, indicating the
material does not harm nor promote growth of this typical intestinal
bacterium. Addition of Hg(II)-S-SAMMS (with the equivalent Hg(II)
of 120 μM) initially slowed growth of the Hg-sensitive strain,
but it fully recovered by 20 h. Addition of Hg–S–SAMMS
to Hg-resistant E. coli had no effect on its growth.
The brief dip in growth rate of the Hg-sensitive strain and the unchanged
growth of the Hg-resistant strain indicated minimal Hg exposures,
perhaps due to the release of surface bound Hg(II) by micromolar monothiols
naturally secreted by bacteria during growth or possibly due to the
presence of Hg bound to thiols external to the pores. Clearly most
of the Hg(II) bound on SH-SAMMS was not accessible to the bacteria.
SH-SAMMS’s effective sequestration of Hg(II) from intestinal
bacteria will thus prevent enrichment of bacteria with genes for Hg(II)
resistance and their genetically linked, transmissible antibiotic
resistance genes[47,51−53] and will also
limit availability of Hg(II) for methylation by intestinal methanogens
and sulfate reducing bacteria.
Figure 4
Cell density (OD600) of (A) Hg-sensitive E. coli and (B) Hg-resistant E. coli after
exposure to 10–50 μM HgCl2, 120 μM Hg
bound to SH-SAMMS (0.1 g/L), SH-SAMMS (0.1 g/L), or untreated. Overnight E. coli cultures were diluted 100× into fresh Luria–Bertani
Broth and treated 3.5 h later.
Cell density (OD600) of (A) Hg-sensitive E. coli and (B) Hg-resistant E. coli after
exposure to 10–50 μM HgCl2, 120 μM Hg
bound to SH-SAMMS (0.1 g/L), SH-SAMMS (0.1 g/L), or untreated. Overnight E. coli cultures were diluted 100× into fresh Luria–Bertani
Broth and treated 3.5 h later.
Low Cytotoxicity of SH-SAMMS and Hg-Bound SH-SAMMS to Intestinal
Tissue Culture Cells
The Caco-2 cell line morphologically
and functionally resembles the epithelial cells (enterocytes) lining
the small intestine. We sought to establish a safety profile of the
SAMMS material in this relevant in vitro cell model. We found SH-SAMMS
to have low cytotoxicity for Caco-2 cells after 24-h exposure at doses
from 0 to 10,000 μg/mL, whereas detectable toxicity of DMSA
and DMPS was observed at 1,000 μg/mL and became severe at 5,000
μg/mL and above (Figure 5A). Although
SH-SAMMS is not bioequivalent of soluble and absorbable DMSA and DMPS,
they all are given orally and the cells of the GI tract will be exposed
to the drugs. The Caco-2 cell represents the best qualitative prediction
because it is closest to the site of action. The low cytotoxicity
of SH-SAMMS is due to the fact that SH-SAMMS is not water-soluble
and not taken up in the cells. It was demonstrated previously that
SH-SAMMS >5 μm in particle size was not uptaken to Caco-2
cells and kept the cell monolayer integrity intact.[12] It is worth noting that we compare the material safety
on a per mass basis rather than molar basis of active components to
mimic the prescribed dose of oral DMSA and DMPS (in mg/day). In addition, safety
of SH-SAMMS should be considered as whole material (include the inactive
silica substrate) and not just for active thiol groups. Nevertheless,
when comparing active ingredients by molar basis, 10 000 μg/mL
of SH-SAMMS contains 28 μmol/mL of thiol which is on par with
5000 μg/mL of DMSA (27 μmol/mL) or DMPS (22 μmol/mL).
At these similar molar concentrations, SH-SAMMS is still the safest
for Caco-2 cells.
Figure 5
(A) Cell viability of Caco-2 cells after 24 h exposure
to individual agents: SH-SAMMS (solid gray bar), DMSA (vertical striped
gray bar), or DMPS (striped bar) at indicated dose range; and (B)
the cell viability after 24 h exposure to MeHg(I) and Hg(II) as soluble
species (white bar) and as SH-SAMMS bound (gray bar).
(A) Cell viability of Caco-2 cells after 24 h exposure
to individual agents: SH-SAMMS (solid gray bar), DMSA (vertical striped
gray bar), or DMPS (striped bar) at indicated dose range; and (B)
the cell viability after 24 h exposure to MeHg(I) and Hg(II) as soluble
species (white bar) and as SH-SAMMS bound (gray bar).In Figure 5B, soluble Hg
species, in the range of 0.04–0.32 mM for Hg(II) or 0.01–0.04
mM for MeHg(I), were highly toxic to Caco-2 cells exhibiting a Lethal
Dose, 50% (LD50) of 0.17 mM for Hg(II) and 0.035 mM for
MeHg(I). In contrast, equivalent doses of both Hg species (Hg(II)
and MeHg(I)) were not toxic when bound to SH-SAMMS. This protection
against mercury toxicity was maintained even when using 4-fold less
SH-SAMMS for loading the maximum Hg studied, 0.32 mM Hg(II) or 0.04
mM MeHg(I) (data not shown).
SH-SAMMS for Oral Mercury Detoxification:
In Vivo Studies
Because of its encouraging in vitro performance,
SH-SAMMS was evaluated in rats for detoxification of MeHg(I), experiencing
concurrent multi-metal stress. Rats on a metal-rich diet + SH-SAMMS
had blood Hg levels much lower than rats fed the metal-rich diet alone
(Figure 6A). When the metal-rich diet was stopped
after 2 weeks, blood Hg levels in rats subsequently fed with the SH-SAMMS
diet decreased faster and to a greater extent than in rats on the
normal diet follow-on regime. SH-SAMMS use also prevented the weight
loss typically associated with heavy metaltoxicity (MS vs M, Figure 6B). Indeed, when the metal-rich diet was stopped,
rats subsequently fed with SH-SAMMS gained weight, whereas rats switched
to the normal diet continued to lose weight (see S vs N, Figure 6B). Thus, enhanced removal of previously accumulated
mercury by SH-SAMMS assists recovery of the rats from prior toxic
effects of heavy metals. Rats fed the SH-SAMMS diet alone gained weight
normally (Figure 6B, (I) S), supporting the
safety and biocompatibility of the material when administered orally.
Figure 6
(A) Blood
Hg content, (B) bodyweight, and (C) Hg contents in organs of rats
after the following dietary treatment exposures (inset protocol flowchart):
the initial phase (denoted I) consisted of 2 weeks of diet containing
0.01 wt % metals (Cd(II), Pb(II), and MeHg(I) (denoted M), 1.0 wt
% SH-SAMMS (denoted S), or both (denoted MS) and then the second phase
(denoted II) after regroupings to compare SH-SAMMS intervention (denoted
S) to normal diet (denoted N) for another 2 weeks. p-values compared to no-SAMMS counterparts for (A) and “(I)
M, (II) N” group for (C). Graphical inset used to expand low
end scale for respective organs.
(A) Blood
Hg content, (B) bodyweight, and (C) Hg contents in organs of rats
after the following dietary treatment exposures (inset protocol flowchart):
the initial phase (denoted I) consisted of 2 weeks of diet containing
0.01 wt % metals (Cd(II), Pb(II), and MeHg(I) (denoted M), 1.0 wt
% SH-SAMMS (denoted S), or both (denoted MS) and then the second phase
(denoted II) after regroupings to compare SH-SAMMS intervention (denoted
S) to normal diet (denoted N) for another 2 weeks. p-values compared to no-SAMMS counterparts for (A) and “(I)
M, (II) N” group for (C). Graphical inset used to expand low
end scale for respective organs.The Hg contents per gram of wet tissue at sacrifice (Figure 6C) revealed Hg accumulated in kidneys > liver
> muscle ≈ bone ≈ brain. Rats fed the SH-SAMMS diet
throughout the study had the lowest Hg accumulation, compared to those
fed partially with SH-SAMMS, and those fed without SH-SAMMS. Thus,
SH-SAMMS not only reduced the absorption of MeHg(I) when given concurrently,
but also accelerated clearance of Hg deposited in the target organs.
Capture of Dietary Cd(II) and Pb(II) in Rats
In addition
to MeHg(I), SH-SAMMS effectively captured Cd(II) and Pb(II) from the
diet as shown in Figure 7. Inorganic Cd(II)
and Pb(II) are typically absorbed more poorly than mercurials and
were detected in blood at much lower levels than MeHg(I). Pb was below
detection in most tissues except bones (∼1–2 μg
Pb/g of bone). However, the lower blood Pb with SH-SAMMS treatment
compared to the no SH-SAMMS group was significant as shown in Figure 7A. Cd accumulated in liver ≈ kidney >
bone > brain ≈ muscle, but the levels were 10- to 100-fold
lower than Hg loading in the same organs (Figure 6C). SH-SAMMS consistently lowered Cd in these tissues as shown
in Figure 7B.
Figure 7
(A) Blood Pb in rats after first 2 weeks
of treatment and (B) tissue Cd levels in rats after 4 weeks of treatment.
Exposure intervals to the metal diet and SH-SAMMS are in Figure 6. Graphical inset used to expand low scale for respective
organs.
(A) Blood Pb in rats after first 2 weeks
of treatment and (B) tissue Cd levels in rats after 4 weeks of treatment.
Exposure intervals to the metal diet and SH-SAMMS are in Figure 6. Graphical inset used to expand low scale for respective
organs.
Capture of Essential Minerals
It is especially noteworthy that while largely preventing the accumulation
of MeHg(I) by rat organs, SH-SAMMS did not diminish the blood contents
of essential bulk and trace elements as shown in Figure 8. Unlike systemically administered chelating agents, SH-SAMMS
exposure is restricted to the GI tract, and hence did not deplete
most essential metal ions as measured in blood. Copper (Cu) could
be captured by SH-SAMMS in vitro (Table 3),
but its loss due to SH-SAMMS was much less dramatic when evaluated
in animals. Blood Cu declined about 10% from prepretreatment levels
after 2 days on SH-SAMMS, more importantly, levels did not decrease
further after 5, 9, and 12 days of treatment. Interestingly, rats
exposed to the heavy metals also had reduced blood Cu levels and the
difference between the blood Cu levels of rats treated with SH-SAMMS
or treated with heavy metals was not significant (p > 0.5) throughout the 12 days of treatment.
Figure 8
Blood contents of essential
metals of rats after the first 2 weeks of treatment as in Figure 6 (M, S, and MS). Graphical inset displays blood
content of some biologically essential metals.
Blood contents of essential
metals of rats after the first 2 weeks of treatment as in Figure 6 (M, S, and MS). Graphical inset displays blood
content of some biologically essential metals.
Conclusions
Our results show that SH-SAMMS has great
potential for the detoxification of heavy metals. The treatment is
a simple oral administration and the material properties can be engineered
as therapeutic needs dictate. This novel application is enabled by
the installation of high sorption affinity interfacial chemistry upon
a nontoxic nanoporous silica material. The method was found to be
viable for the treatment of Cd, Pb, and Hg exposure, and especially
effective for the highly toxic methyl mercuryas judged by: (a) its
high affinity and selectivity for Hg and two other toxic metals in
relevant simulated biological fluids and processes; (b) its rapid
metal binding; (c) its large sorption capacity for Hg and toxic metals;
and (d) its resistance to material degradation or to the release of
captured metal ions; (e) even when challenged in the presence of soluble
biological thiols. In terms of cellular interaction and safety; (f)
SH-SAMMS does not damage or enter intestinal epithelial cells (Caco-2);
(g) it has lower toxicity for Caco-2 cells than DMSA and DMPS on the
same mass basis; and (h) the Hg- or MeHg-S-SAMMS complexes are completely
innocuous for Caco-2 cells compared to equivalent doses of soluble
Hg(II) or MeHg(I). We also found that (i) SH-SAMMS removed Hg from
biologically digested fish tissue with minimal removal of several
key nutritional metals; and (j) when orally administered to rodent
animals, SH-SAMMS lowered blood and/or organ levels of MeHg(I), Cd(II),
and Pb(II) but did not diminish essential minerals in blood. SH-SAMMS
are effective in reducing organ load (vs the untreated group), despite
possible competition with endogenous thiols such asH2S
and methanethiol, products of human and microbial metabolism in the
large bowel. Along the GI tract, the monolayer structure of SH-SAMMS
should be largely unaffected and the Hg should be strongly bound via
the thioalkoxide moiety (supported by high Kd values of Hg species going from pH 1.1 to 6.8 in Table 1). The efficacy of SH-SAMMS in the animals may in
part be due to (k) its small pores that render metals
bound in the internal channels which are inaccessible to bacteria.
Bacterial inaccessibility of captured metals is especially important
for Hg exposure since many intestinal bacteria can convert Hg(II)
to membrane permeable Hg(0) or MeHg(I). SH-SAMMS that can immobilize
mercury in the GI tract (l) would enhance the fecal excretion of mercury
by disrupting its enterohepatic recirculation. Although SH-SAMMS does
not absorb into the body, it may enhance the efficacy of current
chelation therapies since SH-SAMMS can disrupt the recirculation of
the toxic metals back from GI tract to the body. And, unlike systemically
administered chelators, long-term use of SH-SAMMS is likely to be
safe since it did not enter circulation, did not chemically burden
the liver or the kidneys, did not impact the epithelial cells, and
actually fostered regain of lost weight in previously intoxicated
rats. Fumed silica has been FDA approved for food and pill additives
for up to 2% by weight. We predict that SH-SAMMS will be as safe since
the anticipated dose will likely be smaller and because SH-SAMMS has
a much larger particle size, it will have less chance to absorb into
the body. Longer term safety studies are underway and will be reported
in due course. Disulfide bridges may form on SH-SAMMS when exposed
to vigorous oxidizing conditions, potentially rendering the material
ineffective for metal capture. However, this oxidation of the material
does not happen spontaneously in air, as evidenced by the fact that
SH-SAMMS have a shelf life of over 3 years in contact with air.
Authors: Yuehe Lin; Sandra K Fiskum; Wassana Yantasee; Hong Wu; Shas V Mattigod; Erich Vorpagel; Glen E Fryxell; Kenneth N Raymond; Jide Xu Journal: Environ Sci Technol Date: 2005-03-01 Impact factor: 9.028
Authors: Glen E Fryxell; Yuehe Lin; Sandy Fiskum; Jerome C Birnbaum; Hong Wu; Ken Kemner; Shelley Kelly Journal: Environ Sci Technol Date: 2005-03-01 Impact factor: 9.028
Authors: A O Summers; J Wireman; M J Vimy; F L Lorscheider; B Marshall; S B Levy; S Bennett; L Billard Journal: Antimicrob Agents Chemother Date: 1993-04 Impact factor: 5.191
Authors: Wassana Yantasee; Glen E Fryxell; Kanda Pattamakomsan; Thanapon Sangvanich; Robert J Wiacek; Brad Busche; Raymond S Addleman; Charles Timchalk; Worapol Ngamcherdtrakul; Natnaree Siriwon Journal: J Hazard Mater Date: 2018-12-14 Impact factor: 10.588
Authors: Meichen Wang; Gopal Bera; Kusumica Mitra; Terry L Wade; Anthony H Knap; Timothy D Phillips Journal: Environ Sci Pollut Res Int Date: 2020-10-02 Impact factor: 4.223